• Vagher J, et al. Germline predisposition to soft tissue sarcoma. J Cancer Metastasis Treat. 2022;8:31. This reference is important as it has provided a detailed review of common soft tissue sarcomas related to cancer predisposition syndromes.

Zhang J, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373(24):2336–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chavarri-Guerra Y, et al. Genetic cancer predisposition syndromes among older adults. J Geriatr Oncol. 2020;11(7):1054–60.

Article  PubMed  PubMed Central  Google Scholar 

•• Kumamoto T, et al. Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1. Int J Clin Oncol. 2021;26:2161–2178. This article is of major importance as it provides screening guidelines for LFS.

Vogt A, et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2): e000172.

Article  PubMed  PubMed Central  Google Scholar 

Li H, et al. Germline cancer predisposition variants in pediatric rhabdomyosarcoma: a report from the children’s oncology group. JNCI J Natl Cancer Inst. 2021;113(7):875–883.

Fair D, et al. TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children’s Oncology Group report. Pediatr Blood Cancer. 2023;70(9): e30413.

Article  CAS  Google Scholar 

Schultz KAP, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018;24(10):2251–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Apellaniz-Ruiz M, McCluggage WG, Foulkes WD. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: pathology, molecular genetics, and indications for molecular testing. Genes Chromosomes Cancer. 2021;60(3):217–33.

Article  CAS  PubMed  Google Scholar 

Martin-Giacalone BA, et al. Pediatric Rhabdomyosarcoma: epidemiology and genetic susceptibility. J Clin Med. 2021;10(9):2028.

Article  PubMed  PubMed Central  Google Scholar 

Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet. 1995;56(1):112–5.

Article  CAS  PubMed  Google Scholar 

Mussa A, et al. Cancer risk in Beckwith-Wiedemann syndrome: a systematic review and meta-analysis outlining a novel (epi)genotype specific histotype targeted screening protocol. J Pediatr. 2016;176:142–149 e1.

Ducatman BS, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57(10):2006–21.

Wong WW, et al. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys. 1998;42(2):351–60.

Article  CAS  PubMed  Google Scholar 

Anghileri M, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer: Interdiscip Int J Am Cancer Soc. 2006;107(5):1065–1074.

Evans DG, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002;39(5):311–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stucky CC, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol. 2012;19(3):878–85.

Article  PubMed  Google Scholar 

Evans DG, Huson SM, Birch JM. Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res. 2012;2(1):17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brohl AS, et al. Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma. Genet Med. 2017;19(8):955–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gillani R, et al. Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. Am J Hum Genet. 2022;109(6):1026–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirabello L, et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. JAMA Oncol. 2020;6(5):724–34.

Article  PubMed  PubMed Central  Google Scholar 

Diessner BJ, et al. Nearly half of TP53 germline variants predicted to be pathogenic in patients with osteosarcoma are de novo: a report from the Children’s Oncology Group. JCO Precis Oncol. 2020;4:1187–95.

Article  Google Scholar 

Calvert GT, et al. At-risk populations for osteosarcoma: the syndromes and beyond. Sarcoma. 2012;2012: 152382.

Article  PubMed  PubMed Central  Google Scholar 

Wong FL, et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA. 1997;278(15):1262–7.

Article  CAS  PubMed  Google Scholar 

Bougeard G, et al. Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345–52.

Article  CAS  PubMed  Google Scholar 

Villani A, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol. 2011;12(6):559–67.

Article  CAS  PubMed  Google Scholar 

de Andrade KC, et al. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. Lancet Oncol. 2021;22(12):1787–98.

Article  PubMed  PubMed Central  Google Scholar 

Kleinerman RA, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23(10):2272–9.

Article  PubMed  Google Scholar 

MacCarthy A, et al. Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004. Br J Cancer. 2013;108(12):2455–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bright CJ, et al. Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe. JNCI J Natl Cancer Inst. 2018;110(6): 649–660.

Kleinerman RA, et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst. 2007;99(1):24–31.

Article  PubMed  Google Scholar 

Hensley ML, et al. Genomic landscape of uterine sarcomas defined through prospective clinical sequencing. Clin Cancer Res. 2020;26(14):3881–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jonsson P, et al. Tumour lineage shapes BRCA-mediated phenotypes. Nature. 2019;571(7766):576–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kraft S, Fletcher CD. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous “leiomyosarcoma.” Am J Surg Pathol. 2011;35(4):599–607.

Article  PubMed  Google Scholar 

Fallen T, et al. Desmoid tumors–a characterization of patients seen at Mayo Clinic 1976–1999. Fam Cancer. 2006;5(2):191–4.

Article  PubMed  Google Scholar 

Eaton KW, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56(1):7–15.

Article  PubMed  PubMed Central  Google Scholar 

Bourdeaut F, et al. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res. 2011;17(1):31–8.

Article  CAS  PubMed  Google Scholar 

Foulkes WD, et al. Cancer surveillance in Gorlin syndrome and rhabdoid tumor predisposition syndrome. Clin Cancer Res. 2017;23(12):e62–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schneppenheim R, et al. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet. 2010;86(2):279–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nemes K, Bens S, Bourdeaut F. Rhabdoid tumor predisposition syndrome, 2017 Dec 7. GeneReviews®[Internet]. Seattle: University of Washington; 1993.

Hirota S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–80.

Article  CAS  PubMed  Google Scholar 

Ponti G, et al. Gastrointestinal stromal tumor and other primary metachronous or synchronous neoplasms as a suspicion criterion for syndromic setting. Oncol Rep. 2010;23(2):437–44.

CAS  PubMed  Google Scholar 

Postow MA, Robson ME. Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications. Clin Sarcoma Res. 2012;2(1):16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chompret A, et al. PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology. 2004;126(1):318–21.

Article  CAS  PubMed  Google Scholar